Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mylan has signed a license and supply agreement with Natco Pharma for its glatiramer acetate pre-filled syringes, a generic version of Teva's Copaxone, which is used to treat multiple sclerosis.
Subscribe to our email newsletter
The agreement grants Mylan exclusive distribution rights in the US and all major markets in Europe, Australia, New Zealand, Japan and Canada and includes an option to expand into additional territories.
Mylan said that Natco has commercialized successfully its glatiramer acetate product in India and the Ukraine.
Robert Coury, vice chairman and CEO of Mylan, said: “We are extremely pleased to be collaborating with Natco to market and distribute this critically important product virtually worldwide.”